Experimental Alzheimer’s medication reduces cognitive deterioration by 27%
1800 Alzheimer’s patients at varying stages participated in the study. There is some good news for Alzheimer’s patients as an experimental treatment has demonstrated great success in delaying the decrease in cognitive and functional abilities by roughly 27%, according to the drug’s manufacturers. Lecanemab, a medicine created by American corporation Biogen and Japanese pharmaceutical company […]
